IRE1BETA inhibitors: novel therapeutics to manage excess mucus in asthma
Ended Project Grant Awarded Last action
- Award ID
- R41AI142847
- Recipient
-
Irex Pharma LLC UEI P71WTGEVLDS3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $599,999
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Place of performance
- North Carolina, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $299,999 | |
| Original award | $300,000 |
Quick answers
Who received award R41AI142847?
R41AI142847 was awarded to Irex Pharma LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on April 19, 2019.
How much is award R41AI142847 worth?
$599,999 has been obligated on R41AI142847.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award